Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 9/23/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Thomas F. Schaible PhD

Wrong Dr. Thomas F. Schaible PhD?

Integration: Default Position

Phone: (215) ***-****  
Email: t***@***.com
Local Address:  Horsham , Pennsylvania , United States
Johnson & Johnson
One Johnson & Johnson Plz
New Brunswick , New Jersey 08933
United States

Company Description: Johnson & Johnson manufactures and sells of a broad range of products in the health care field. It conducts business in virtually all countries. The Company's...   more

Employment History


  • PhD , physiology
    Rutgers University
  • BS , biology
    Trinity College
  • Ph.D.
78 Total References
Web References
Remicade Lawyers - Remicade Side Effects Attorneys - Rheumatoid Arthritis Treatment - Pharmaceutical Litigation Law Firm, 17 May 2006 [cached]
Tom Schaible, vice president of medical affairs at Johnson & Johnson's Centocor unit, said, "We don't really know if these tumors are drug-related or not, but because they occur we report them in our label.", 18 June 2002 [cached]
"Rheumatoid arthritis can be an extremely debilitating disease," said Thomas Schaible, Ph.D., executive director, medical affairs, Centocor.
As CKD severity progresses in patients ..., 27 June 2011 [cached]
As CKD severity progresses in patients not on dialysis, anemia becomes more frequent and severe, and is almost universal among patients requiring dialysis," said Thomas Schaible, Ph.D., Vice President, Medical Affairs, Janssen Products, LP.
Speaker Bio's | the state of clinical development conference - january 10-11, 2012, philadelphia pa |, 4 Mar 2014 [cached]
Tom Schaible Vice President of Medical Affairs, Jannsen Bio pharm at Johnson & Johnson
Society : The Society - News from Reuters, 4 Mar 2003 [cached]
Remicade's label also includes clinical trial data regarding malignancies and says it is insufficient to determine whether the drug is related, said Tom Schaible, Vice President for Medical Affairs for Johnson & Johnson's Centocor unit.
"The unmet medical need met by Remicade provides a benefit-risk relationship that is clearly in favor of benefit," he added.
Other People with the name "Schaible":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.